ENTITY
D.Western Therapeutics Institute Inc.

D.Western Therapeutics Institute Inc. (4576 JP)

25
Analysis
Health Care • Japan
D.Western Therapeutics Institute Inc.(DWTI) is a biotechnology (bio-venture) company that focuses on development of new drugs. The Company's focus is on protein kinase inhibitors. DWTI discovers and develops several drugs, such as antiglaucoma, antihypertensive, neuroprotective, antithrombogenic, antiatherosclerosis and anticancer.
more
•26 Nov 2025 23:53•Issuer-paid

D. Western Therapeutics Institute (DWTI) (4576 JP) - November 21, 2025

SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last year.

Share
•05 Nov 2025 20:47•Issuer-paid

News Flash: D. Western Therapeutics Institute (4576 JP) - November 5, 2025

DWTI announced after the close on 11/4 that 84.6% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July...

Share
•02 Oct 2025 19:46•Issuer-paid

News Flash - D. Western Therapeutics Institute (4576 JP) - October 2, 2025

DWTI announced after the close on 10/1 that 74.0% of the Series 13 Share Acquisition Rights (with exercise price adjustment clause) issued on July...

Share
•25 Sep 2025 20:08•Issuer-paid

D. Western Therapeutics Institute (4576 JP) - September 25, 2025

DWTI announced before the open on 9/25 that the US FDA (Food and Drug Administration) has granted marketing approval for DW-5LBT (lidocaine patch,...

Share
•05 Sep 2025 19:51•Issuer-paid

Q2 Follow-Up - D. Western Therapeutics Institute (DWTI) (4576 JP) - September 4, 2025

SIR believes DWTI has entered an exciting new phase given significant advances in pipeline development achieved over the last year.

Share
x